Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2011
03/24/2011US20110070644 Monocyte-Derived Stem Cells (MDSC) and Methods of Use Thereof
03/24/2011US20110070638 Apparatus and method for preparative scale purification of nucleic acids
03/24/2011US20110070626 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
03/24/2011US20110070606 Systems and methods for analyzing body fluids
03/24/2011US20110070605 Reversible mhc multimer staining for functional purification of antigen-specific t cells
03/24/2011US20110070604 Analysis of ex vivo cells for disease state detection and therapeutic agent selection and monitoring
03/24/2011US20110070603 Disc for testing blood, blood tester having the same, and control method thereof
03/24/2011US20110070602 Methods and Apparatuses for Measuring Biological Processes Using Mid-Infrared Spectroscopy
03/24/2011US20110070601 Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40
03/24/2011US20110070594 Method for Detecting Escherichia coli
03/24/2011US20110070591 Replication protein
03/24/2011US20110070590 Primers and Methods for Determining RhD Zygosity
03/24/2011US20110070589 Magnetic lysis method and device
03/24/2011US20110070588 Methods for Identifying Genomic Deletions
03/24/2011US20110070587 System For Genetic Surveillance and Analysis
03/24/2011US20110070586 Multiplex Detection Of Agricultural Pathogens
03/24/2011US20110070585 Integrated nucleic acid analysis
03/24/2011US20110070584 Methods and compositions for diagnosing and monitoring autoimmune and chronic inflammatory diseases
03/24/2011US20110070583 Lsamp gene associated with cardiovascular disease
03/24/2011US20110070582 Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma Subjects
03/24/2011US20110070581 Separation of Leukocytes
03/24/2011US20110070580 Methods, Compositions, and Kits for Amplifying and Sequencing Polynucleotides
03/24/2011US20110070579 Polyketide synthase-nonribosomal peptide synthetase gene
03/24/2011US20110070578 DNA analyzer
03/24/2011US20110070577 Method for Detecting Target Nucleic Acids Using Template Catalyzed Transfer Reactions
03/24/2011US20110070576 Vitro diagnostic kit for identification of human papillomavirus in clinical samples
03/24/2011US20110070574 Method for virus detection
03/24/2011US20110070268 Method
03/24/2011US20110070265 Engineered pertactin variants for vaccine use
03/24/2011US20110070245 Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer
03/24/2011US20110070242 Methods for Diagnosing and Treating Iron Dysregulation
03/24/2011US20110070238 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
03/24/2011US20110070235 Compositions and methods for the therapy and diagnosis of influenza
03/24/2011US20110070230 Method and devices for identifying and treating a subject who has developed an anti-antibody response
03/24/2011US20110070223 Uses of Lp-PLA2 in combination to assess coronary risk
03/24/2011US20110070221 Gnaq mutations in melanoma
03/24/2011US20110070206 Methods of applying physical stimuli to cells
03/24/2011US20110070203 Mesendoderm and mesoderm cell populations
03/24/2011US20110070195 Uses of spatial configuration to modulate protein function
03/24/2011US20110070192 Method of preparation of novel nucleoside analogs and uses
03/24/2011US20110070166 Reduced dye probes for the detection of radical oxygen species
03/24/2011US20110070164 Post release modification of viral envelopes
03/24/2011US20110070162 Rna interference mediating small rna molecules
03/24/2011DE102009042090A1 Individual prognosis of occurrence or progression of and/or for individual diagnosis of neuropathy of mammal, comprises detecting expression of mRNA of a gene in a tissue- or fluid sample of mammal, where the gene is e.g. adiponectin
03/24/2011DE102009040716A1 Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen Use of CD154 for the identification and separation of non-regulatory T cells from a mixture with regulatory T cells
03/24/2011DE102006048264B4 Verfahren zum Nachweis spezifischer Nukleinsäuresequenzen A method for detection of specific nucleic acid sequences
03/24/2011CA2811888A1 Integrated cartridge
03/24/2011CA2774533A1 System for conducting the identification of bacteria in biological samples
03/24/2011CA2774486A1 Na/k-atpase ligands, ouabain antagonists, assays and uses thereof
03/24/2011CA2774475A1 Lassa virus-like particles and methods of production thereof
03/24/2011CA2774462A1 Optical device and method for non-invasive real-time testing of blood sugar levels
03/24/2011CA2774456A1 Cloning and exploitation of a functional r-gene from solanum chacoense
03/24/2011CA2774349A1 Recurrent gene fusions in prostate cancer
03/24/2011CA2774342A1 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
03/24/2011CA2774327A1 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same
03/24/2011CA2774235A1 Methods and kits for the identification of animals having a greater potential for desirable characteristics, and for the early identification of fat deposits in bovines
03/24/2011CA2773666A1 Method for identifying whether a patient will be responder or not to immunotherapy
03/24/2011CA2772670A1 Methods and compositions for diagnostics use in cancer patients
03/24/2011CA2772447A1 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals
03/24/2011CA2770071A1 Enzyme triggered redox altering chemical elimination (e-trace) immunoassay
03/23/2011EP2299377A1 Methods for identifying, diagnosing and predicting survival of lymphomas
03/23/2011EP2299272A2 N-terminally truncated HER-2/NEU protein as a cancerprognostic indicator
03/23/2011EP2299269A1 Protein fragment complementation assay based on beta-lactamase
03/23/2011EP2299268A2 Methods and compositions for diagnosing hepatocellular carcinoma
03/23/2011EP2299266A1 Methods and materials for assessing prostate cancer therapies
03/23/2011EP2299257A2 Device and method for detecting molecular interactions
03/23/2011EP2298938A1 Porcine reproductive and respiratory syndrome isolates and methods of use
03/23/2011EP2298937A1 Methods and kits for linking polymorphic sequences to expanded repeat mutations
03/23/2011EP2298936A1 Genomic fingerprint of mammary cancer
03/23/2011EP2298935A1 Methods for detection of a target nucleic acid sequence
03/23/2011EP2298933A1 Method of diagnosing esophageal cancer
03/23/2011EP2298932A1 Methods and nucleic acids for the analysis of gene expression, in particular methylation of KAAG1, associated with tissue classification
03/23/2011EP2298931A1 Apparatus for performing PCT and monitoring the reaction in real time during temperature cycling
03/23/2011EP2298930A1 Preparation of templates for nucleic acid sequencing
03/23/2011EP2298929A1 Sorting and immobilization system for nucleic acids using synthetic binding systems
03/23/2011EP2298928A2 Biosensor electrode
03/23/2011EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
03/23/2011EP2298921A2 Cotton event MON 88913 and compositions and methods for detection thereof
03/23/2011EP2298902A1 Luciferase biosensor
03/23/2011EP2298899A2 CRSP proteins (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
03/23/2011EP2298895A1 Method of diagnosing small cell lung cancer
03/23/2011EP2298894A1 Methods and compositions involving miRNA and miRNA inhibitor molecules
03/23/2011EP2298886A2 Method for searching target base sequence of RNA interference, method for designing base sequence of polynucleotide for causing RNA interference, method for producing double-stranded polynucleotide, method for inhibiting gene expression, base sequence processing apparatus, program for running base sequence processing method on computer, recording medium, and base sequence processing system
03/23/2011EP2298885A1 PRIMER FOR DETECTION OF TYROSINASE mRNA
03/23/2011EP2298884A1 Method for detection of thermotolerant bacterium
03/23/2011EP2298883A1 Novel selection marker gene and use thereof
03/23/2011EP2298881A1 Nucleic acid molecule having the capacity to bond with a 2,4,6-trinitrophenyl structure, method for detecting compounds including a 2,4,6-trinitrophenyl structure using said nucleic acid molecule, and use of said nucleic acid molecule
03/23/2011EP2298879A1 Method for amplification of dna in cell
03/23/2011EP2298878A2 Compositions and methods for the diagnosis of cancer
03/23/2011EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them
03/23/2011EP2298869A1 Recombinant protein production in the presence of mRNA interferase
03/23/2011EP2298814A2 Method for quantifying phosphokinase activity on proteins
03/23/2011EP2298803A2 Human G-protein coupled receptor and ligands thereof
03/23/2011EP2298802A1 T1R3 taste receptors and genes encoding same
03/23/2011EP2298797A2 Increased bacillus YweA expression
03/23/2011EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits
03/23/2011EP2298791A1 Binding molecules for human factor VIII and factor VIII-like proteins
03/23/2011EP2298787A1 DNA sequencing by parallel oligonucleotide extensions
03/23/2011EP2298786A1 DNA sequencing by parallel oligonucleotide extensions
03/23/2011EP2298785A1 Simultaneous determination of blood group and platelet antigen genotypes